EMEA-000989-PIP01-10-M02
Key facts
| Active substance |
|
| Therapeutic area |
Other
|
| Decision number |
P/0231/2017
|
| PIP number |
EMEA-000989-PIP01-10-M02
|
| Pharmaceutical form(s) |
Solution
|
| Condition(s) / indication(s) |
Prevention of infection prior to invasive procedures
|
| Route(s) of administration |
Cutaneous use
|
| Contact for public enquiries |
3M Health Care Limited
|
| Decision type |
RPM: decision refers to a refusal on the application for modification of an agreed PIP
|